Human cerebral blood flow regulation: sex, mechanism, and stress differences
人类脑血流调节:性别、机制和应激差异
基本信息
- 批准号:10407466
- 负责人:
- 金额:$ 60.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:4D MRIAcuteAddressAdultAgeAgingAgreementAlzheimer&aposs DiseaseAnimalsAnteriorAutomobile DrivingBlood VesselsBlood flowBrainBrain regionCerebral HypoxiaCerebrovascular CirculationCerebrovascular DisordersCerebrovascular PhysiologyCerebrovascular systemCerebrumClinicalDataDementiaDiabetes MellitusDiseaseDisease ProgressionEndotheliumEstradiolEstrogensEtiologyExhibitsFemaleFunctional disorderGoalsGonadal Steroid HormonesHealthHormonesHumanHypercapniaHypertensionHypoxiaKnowledgeLinkLong-Term CareMagnetic Resonance ImagingMediatingMethodsNitric OxideNitric Oxide SynthaseObesityOutcomePatientsPatternPerfusionPharmacologyPhysiologicalPopulationPremenopauseProstaglandin-Endoperoxide SynthaseProstaglandinsQuality of lifeRattusRegulationResearchResearch DesignResolutionRestRiskSex DifferencesSexual ReassignmentSignal TransductionStimulusStressSupplementationTechniquesTestingTestosteroneTherapeuticVasodilationVasodilator AgentsWomanactive controlanimal dataarterial spin labelingbasebrain circulationcerebral arterycerebrovascularclinically relevantcomorbiditydesigndisorder riskfemale sex hormonefunctional restorationgain of functionhigh riskhigh risk populationimproved functioningin vivoinsightjuvenile animalmalemenmultimodal datanovelphysiologic stressorpre-clinicalprogramsregional differenceresponsesexsexual dimorphismstroke risktechnological innovationvascular contributionsvasoconstrictionyoung adult
项目摘要
Project Summary/Abstract
Cerebrovascular disease is the third leading killer in the U.S., and contributes to decreased quality of
life and increased long-term care spending. The risk of cerebrovascular disease is inversely
associated with resting cerebral blood flow (CBF). Men exhibit a lower resting CBF and have twice
the risk of cerebrovascular disease when compared to premenopausal women. The ability of cerebral
vessels to respond to challenges is also inversely related to disease risk, and may be useful in
identifying at-risk patients pre-clinically. However, these studies are often confounded by aging and/or
comorbidities, and the associations provide little insight into physiologic mechanisms responsible for
sexually dimorphic cerebrovascular disease risk. Conversely, animal studies use supraphysiologic
levels of hormone treatment in primarily young animals, which limits the translational relevance of
animal CBF mechanisms. While there is general agreement that estrogen is protective in healthy
adults, the basic impact of sex, and physiologic fluctuations in sex hormones, on mechanisms of CBF
control remains unclear. The overall goal of this research program is to investigate the mechanisms
which actively control cerebral blood flow (CBF) in humans, particularly how men and women differ in
control mechanisms on a regional basis throughout the brain circulation. We propose to study CBF
control mechanisms in healthy younger (18-40 yrs) adult men and women. The overall hypothesis is
that female sex and sex hormones contribute to larger stress-induced increases in CBF, due to
greater prostanoid (COX) and nitric oxide (NOS) dilation. A key technological innovation of this
proposal derives from multi-mode, high-resolution, flow sensitive MRI to quantify CBF at macro- and
microvascular levels, at rest, and in response to environmental challenges. Additionally, the research
design allows us to quantify sex differences in two vascular control mechanisms across all brain
regions. Our preliminary data demonstrate: hypoxic cerebral vasodilation is 60-100% higher in
women compared to men, COX inhibition reduces dilation in women but not men, NOS inhibition
reduces vasodilation more in women, and hypoxic vasodilation is increased in women during early
luteal cycle, in part to greater COX-mediated vasodilation. We also will use sex hormone
suppression, followed by single hormone addition, to systematically study the impacts on CBF control
in both sexes. We have substantial preliminary findings that support our hypotheses, and have
integrated physiologic, pharmacologic, and MRI approaches to test our hypotheses. This state-of-the-
art approach will yield previously unattainable insight into not only maintaining CBF, but actively
controlling it during physiologic demands for increased flow. These novel, high resolution, regionally-
specific, sex-specific, and mechanism-specific findings will serve as a knowledge platform, for
designing sex-specific CBF studies in high risk disease populations (e.g. diabetes, hypertension,
Alzheimer’s) which exhibit strong sex-specific etiology and important vascular contributions.
项目总结/摘要
脑血管疾病是美国的第三大杀手,并降低了
生活和长期护理支出增加。患脑血管疾病的风险与
与静息脑血流量(CBF)相关。男性表现出较低的静息CBF,
与绝经前妇女相比,脑血管疾病的风险。大脑的能力
血管应对挑战的能力也与疾病风险呈负相关,
在临床前识别高危患者。然而,这些研究经常受到老化和/或
合并症,并且该协会几乎没有提供对负责的生理机制的深入了解。
性二态性脑血管病风险。相反,动物研究使用超生理学方法,
主要是年轻动物的激素治疗水平,这限制了
动物CBF机制虽然人们普遍认为雌激素对健康的人有保护作用,
成年人,性别的基本影响,性激素的生理波动,CBF的机制
控制仍然不清楚。这项研究计划的总体目标是调查机制
积极控制人类的脑血流量(CBF),特别是男性和女性在
在整个脑循环的区域基础上的控制机制。我们建议研究CBF
健康年轻(18-40岁)成年男性和女性的控制机制。总的假设是
女性性和性激素有助于更大的压力诱导的CBF增加,由于
前列腺素(考克斯)和一氧化氮(NOS)扩张更大。这一关键技术创新
建议来自多模式,高分辨率,流动敏感MRI,以量化CBF在宏观和
微血管水平,在休息,并响应环境的挑战。此外,研究
设计使我们能够量化整个大脑中两种血管控制机制的性别差异
地区我们的初步数据表明:缺氧性脑血管舒张比对照组高60-100%。
女性与男性相比,考克斯抑制减少女性的扩张,但男性没有,NOS抑制
在女性中减少血管舒张更多,在早期,
黄体周期,部分是因为COX介导的血管舒张作用更强。我们还将使用性激素
抑制,然后添加单一激素,以系统地研究对CBF控制的影响
在两性中。我们有大量的初步发现支持我们的假设,
综合生理学、药理学和MRI方法来验证我们的假设。这种...
艺术方法将产生以前无法实现的洞察力,不仅保持CBF,
在生理需求期间控制它以增加流量。这些新颖的,高分辨率的,区域性的-
具体的、性别具体的和机制具体的研究结果将作为一个知识平台,
设计高风险疾病人群(例如糖尿病,高血压,
阿尔茨海默氏症),表现出强烈的性别特异性病因和重要的血管贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM G SCHRAGE其他文献
WILLIAM G SCHRAGE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM G SCHRAGE', 18)}}的其他基金
Human cerebral blood flow regulation: sex, mechanism, and stress differences
人类脑血流调节:性别、机制和应激差异
- 批准号:
10650368 - 财政年份:2020
- 资助金额:
$ 60.71万 - 项目类别:
Insulin resistance, cognitive health, and perfusion of the adolescent brain
胰岛素抵抗、认知健康和青少年大脑灌注
- 批准号:
9980475 - 财政年份:2019
- 资助金额:
$ 60.71万 - 项目类别:
Aging and Microvascular Dysfunction in Human Skeletal Muscle
人体骨骼肌的衰老和微血管功能障碍
- 批准号:
7587863 - 财政年份:2009
- 资助金额:
$ 60.71万 - 项目类别:
Aging and Microvascular Dysfunction in Human Skeletal Muscle
人体骨骼肌的衰老和微血管功能障碍
- 批准号:
7770776 - 财政年份:2009
- 资助金额:
$ 60.71万 - 项目类别:
Muscle Pump and Chemical Dilation in Exercise Hyperemia
运动充血中的肌肉泵和化学扩张
- 批准号:
6710162 - 财政年份:2002
- 资助金额:
$ 60.71万 - 项目类别:
Muscle Pump and Chemical Dilation in Exercise Hyperemia
运动充血中的肌肉泵和化学扩张
- 批准号:
6447034 - 财政年份:2002
- 资助金额:
$ 60.71万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 60.71万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 60.71万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 60.71万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 60.71万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 60.71万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 60.71万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 60.71万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 60.71万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 60.71万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 60.71万 - 项目类别:
Standard Grant